Enanta Pharmaceuticals (ENTA) SEC Filings & 10K Form

$12.92
-0.23 (-1.75%)
(As of 04/24/2024 ET)

Recent Enanta Pharmaceuticals SEC Filings

DateFilerForm TypeView
03/08/2024
4:23 PM
Enanta Pharmaceuticals (Issuer)
Peterson Kristine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:27 PM
Enanta Pharmaceuticals (Issuer)
Russell Lesley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:30 PM
Enanta Pharmaceuticals (Issuer)
Vance Terry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:15 PM
Enanta Pharmaceuticals (Issuer)
FOLETTA MARK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:19 PM
Enanta Pharmaceuticals (Issuer)
Hata Yujiro S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:12 PM
CARTER BRUCE L A (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:31 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
12:11 PM
Enanta Pharmaceuticals (Subject)
Krensavage Asset Management, LLC (Filed by)
Form SCHEDULE 13G
02/14/2024
7:21 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:23 PM
Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:00 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:09 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:12 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:15 PM
Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:18 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
1:26 PM
ARMISTICE CAPITAL, LLC (Filed by)
Enanta Pharmaceuticals (Subject)
Form SC 13G/A
02/08/2024
11:15 PM
Enanta Pharmaceuticals (Filer)
Form EFFECT
01/26/2024
8:11 AM
Enanta Pharmaceuticals (Subject)
Farallon Capital Partners, L.P. (Filed by)
Form SC 13G/A
01/24/2024
4:23 PM
BlackRock Inc. (Filed by)
Enanta Pharmaceuticals (Subject)
Form SC 13G/A
01/22/2024
11:25 AM
Enanta Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/11/2024
3:15 PM
Enanta Pharmaceuticals (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G
12/15/2023
7:08 PM
Enanta Pharmaceuticals (Issuer)
Vance Terry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
4:16 PM
Enanta Pharmaceuticals (Subject)
Vance Terry (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2023
7:26 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:29 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:31 PM
Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:17 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:19 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:22 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:24 PM
Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:24 PM
Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:08 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:11 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:15 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:19 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:21 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:10 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:10 PM
Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:11 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:11 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:12 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Bitcoin Rockets To Record High But Buy THIS Instead (Ad)

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.
11/22/2023
4:12 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:12 PM
Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
3:38 PM
Enanta Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/22/2023
3:12 PM
Enanta Pharmaceuticals (Filer)
Form POSASR
11/22/2023
3:21 PM
Enanta Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
11/16/2023
3:31 PM
Enanta Pharmaceuticals (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G
10/06/2023
1:34 PM
BlackRock Inc. (Filed by)
Enanta Pharmaceuticals (Subject)
Form SC 13G/A
06/07/2023
6:01 AM
Enanta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ENTA) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners